These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 12140666

  • 1. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauer G.
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [Abstract] [Full Text] [Related]

  • 2. Fasting insulin and HOMA-index changes in patients treated with valproic acid.
    Mania M, Javashvili L, Kasradze S, Okujava N.
    Georgian Med News; 2011 Oct; (199):48-52. PubMed ID: 22155806
    [Abstract] [Full Text] [Related]

  • 3. Insulin-related metabolic changes during treatment with valproate in patients with epilepsy.
    Pylvänen V, Pakarinen A, Knip M, Isojärvi J.
    Epilepsy Behav; 2006 May; 8(3):643-8. PubMed ID: 16600693
    [Abstract] [Full Text] [Related]

  • 4. Obesity and endocrine disorders in women taking valproate for epilepsy.
    Isojärvi JI, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KT, Myllylä VV.
    Ann Neurol; 1996 May; 39(5):579-84. PubMed ID: 8619542
    [Abstract] [Full Text] [Related]

  • 5. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
    El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS, Hakky SM, El Barbary NS, Nassef NM.
    Epilepsia; 2004 Sep; 45(9):1106-15. PubMed ID: 15329076
    [Abstract] [Full Text] [Related]

  • 6. Valproic Acid related metabolic syndrome in patients with epilepsy.
    Mania M, Kasradze S, Okujava N.
    Georgian Med News; 2011 May; (194):43-7. PubMed ID: 21685521
    [Abstract] [Full Text] [Related]

  • 7. A meta-analysis of polycystic ovary syndrome in women taking valproate for epilepsy.
    Hu X, Wang J, Dong W, Fang Q, Hu L, Liu C.
    Epilepsy Res; 2011 Nov; 97(1-2):73-82. PubMed ID: 21820873
    [Abstract] [Full Text] [Related]

  • 8. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
    Kim JY, Lee HW.
    Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
    [Abstract] [Full Text] [Related]

  • 9. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
    Voudris KA, Attilakos A, Katsarou E, Drakatos A, Dimou S, Mastroyianni S, Skardoutsou A, Prassouli A, Garoufi A.
    Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
    [Abstract] [Full Text] [Related]

  • 10. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV.
    N Engl J Med; 1993 Nov 04; 329(19):1383-8. PubMed ID: 8413434
    [Abstract] [Full Text] [Related]

  • 11. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
    Sahota P, Prabhakar S, Kharbanda PS, Bhansali A, Jain V, Das CP, Modi M.
    Epilepsia; 2008 Dec 04; 49(12):2069-77. PubMed ID: 18503558
    [Abstract] [Full Text] [Related]

  • 12. Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.
    Gorkemli H, Genc BO, Dogan EA, Genc E, Ozdemir S.
    Gynecol Obstet Invest; 2009 Dec 04; 67(4):223-7. PubMed ID: 19246930
    [Abstract] [Full Text] [Related]

  • 13. Increase in postprandial serum insulin levels in epileptic patients with valproic acid therapy.
    Luef G, Abraham I, Hoppichler F, Trinka E, Unterberger I, Bauer G, Lechleitner M.
    Metabolism; 2002 Oct 04; 51(10):1274-8. PubMed ID: 12370846
    [Abstract] [Full Text] [Related]

  • 14. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E, Rodríguez-López CM, Cano MD, Peña-Bernal M.
    Rev Neurol; 1998 Nov 04; 27(159):785-9. PubMed ID: 9859151
    [Abstract] [Full Text] [Related]

  • 15. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H.
    Epilepsia; 2007 Mar 04; 48(3):470-7. PubMed ID: 17326798
    [Abstract] [Full Text] [Related]

  • 16. Valproate-induced insulin resistance and obesity in children.
    Verrotti A, la Torre R, Trotta D, Mohn A, Chiarelli F.
    Horm Res; 2009 Mar 04; 71(3):125-31. PubMed ID: 19188736
    [Abstract] [Full Text] [Related]

  • 17. Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.
    Rakitin A, Kõks S, Haldre S.
    Seizure; 2016 May 04; 38():11-6. PubMed ID: 27061880
    [Abstract] [Full Text] [Related]

  • 18. Polycystic ovary syndrome in women using valproate: a review.
    Bilo L, Meo R.
    Gynecol Endocrinol; 2008 Oct 04; 24(10):562-70. PubMed ID: 19012099
    [Abstract] [Full Text] [Related]

  • 19. States of serum leptin and insulin in children with epilepsy: risk predictors of weight gain.
    Hamed SA, Fida NM, Hamed EA.
    Eur J Paediatr Neurol; 2009 May 04; 13(3):261-8. PubMed ID: 18586538
    [Abstract] [Full Text] [Related]

  • 20. Evaluate the effects of antiepileptic drugs on reproductive endocrine system in newly diagnosed female epileptic patients receiving either Valproate or Lamotrigine monotherapy: A prospective study.
    Sidhu HS, Srinivasa R, Sadhotra A.
    Epilepsy Res; 2018 Jan 04; 139():20-27. PubMed ID: 29144993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.